Please try another search
Neuroderm Ltd., a clinical-stage pharmaceutical company that develops and manufactures pharmaceutical products for the treatment of central nervous system (CNS) disorders. The company develop a liquid formulation of levodopa/carbidopa (LD/CD) that increases dopamine concentrations in the brain, improves nerve conduction, and alleviates movement disorders related to Parkinson’s disease. It also develops ND0701, a subcutaneously delivered apomorphine formulation for patients who suffer from moderate to severe Parkinson’s disease. The company provides clinical trial for the treatment of cognition disorders associated with CNS diseases, such as ADD/ADHD, Alzheimer’s disease, and schizophrenia. Neuroderm Ltd. was founded in 2003 and is based in Rehovot, Israel. As of October 18, 2017, Neuroderm Ltd. operates as a subsidiary of Mitsubishi Tanabe Pharma Corporation.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review